[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Natera Inc (NTRA)

Natera Inc (NTRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 48,534,724
  • Shares Outstanding, K 144,144
  • Annual Sales, $ 2,306 M
  • Annual Income, $ -208,160 K
  • EBIT $ -277 M
  • EBITDA $ -233 M
  • 60-Month Beta 1.51
  • Price/Sales 20.48
  • Price/Cash Flow N/A
  • Price/Book 25.77

Options Overview Details

View History
  • Implied Volatility 41.12% (-1.28%)
  • Historical Volatility 64.06%
  • IV Percentile 20%
  • IV Rank 14.21%
  • IV High 76.67% on 04/23/26
  • IV Low 35.23% on 08/28/25
  • Expected Move (DTE 23) 24.14 (7.13%)
  • Put/Call Vol Ratio 0.84
  • Today's Volume 226
  • Volume Avg (30-Day) 1,591
  • Put/Call OI Ratio 1.16
  • Today's Open Interest 24,284
  • Open Int (30-Day) 32,636
  • Expected Range 314.31 to 362.59

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 23 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/26
See More
  • Average Estimate $-0.10
  • Number of Estimates 4
  • High Estimate $0.13
  • Low Estimate $-0.20
  • Prior Year $-0.64
  • Growth Rate Est. (year over year) +84.38%

Price Performance

See More
Period Period Low Period High Performance
1-Month
248.03 +36.46%
on 07/29/26
340.96 -0.74%
on 08/26/26
+76.46 (+29.18%)
since 07/24/26
3-Month
196.44 +72.29%
on 05/27/26
340.96 -0.74%
on 08/26/26
+137.54 (+68.46%)
since 05/26/26
52-Week
157.43 +114.99%
on 10/02/25
340.96 -0.74%
on 08/26/26
+172.74 (+104.24%)
since 08/26/25

Most Recent Stories

More News
3 Large-Cap Stocks Worth Investigating

3 Large-Cap Stocks Worth Investigating

CPRT : 32.67 (-1.98%)
NTRA : 338.45 (+0.52%)
CI : 280.87 (+0.55%)
2 Biotech Stocks Shaping Up for Major Breakouts

Moderna's mRNA cancer vaccine breakthrough with Merck fueled a biotech rally, with the IBB near highs. Eli Lilly and Natera both show strong uptrends and possible breakouts.

NTRA : 338.45 (+0.52%)
MRK : 153.10 (-2.14%)
IBB : 215.23 (-0.54%)
LLY : 1,189.41 (-3.59%)
MRNA : 149.66 (-5.77%)
Duquesne Management Opens New Position in Alphabet Stock as Google Posts Blowout Q2 Results

Duquesne Family Office just built a fresh stake in Alphabet stock as Google's AI and cloud business posts blowout Q2 growth.

GOOGL : 342.00 (-1.43%)
UAL : 114.83 (-2.20%)
DHI : 149.25 (-1.03%)
HUT : 85.00 (-0.58%)
STM : 49.66 (+0.40%)
FLR : 52.03 (+1.50%)
TSM : 417.69 (+0.07%)
NTRA : 338.45 (+0.52%)
CDW : 141.46 (-0.44%)
AMD : 480.93 (+0.37%)
AMZN : 260.28 (-0.30%)
PANW : 339.31 (-0.17%)
Q2 Rundown: Natera (NASDAQ:NTRA) Vs Other Biotechnology Stocks

Q2 Rundown: Natera (NASDAQ:NTRA) Vs Other Biotechnology Stocks

NTRA : 338.45 (+0.52%)
5 Insightful Analyst Questions From Natera’s Q2 Earnings Call

5 Insightful Analyst Questions From Natera’s Q2 Earnings Call

NTRA : 338.45 (+0.52%)
Natera to Support New Clinical Trial Assessing ctDNA Dynamics with Latitude™ in Advanced Skin Cancers

Phase I trial in Germany will support treatment response monitoring for Kupando Therapeutics’ investigational immunotherapy using Latitude MRD testing

NTRA : 338.45 (+0.52%)
NTRA Q2 Deep Dive: Oncology Milestones and New Product Launches Drive Growth

NTRA Q2 Deep Dive: Oncology Milestones and New Product Launches Drive Growth

NTRA : 338.45 (+0.52%)
Stocks Settle Higher as a Weak Jobs Report Allays Rate Hike Fears

The S&P 500 Index ($SPX ) (SPY ) closed up +0.62% on Friday, the Dow Jones Industrial Average ($DOWI ) (DIA ) closed up +0.28%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +1.19%. September E-mini...

HL : 20.70 (-1.03%)
CDE : 21.44 (-0.69%)
ADI : 371.80 (-0.50%)
ABNB : 188.07 (-1.28%)
SCCO : 213.75 (-2.71%)
DOCS : 24.74 (unch)
SPY : 766.08 (+0.02%)
ADSK : 254.77 (+1.42%)
ORCL : 148.87 (+2.84%)
QQQ : 711.37 (+0.09%)
AU : 118.11 (-4.28%)
NOW : 125.80 (-0.94%)
Stocks Supported as Fed Rate Hike Fears Ease

The S&P 500 Index ($SPX ) (SPY ) today is up +0.61%, the Dow Jones Industrial Average ($DOWI ) (DIA ) is up +0.25%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +1.00%. September E-mini S&P futures...

HL : 20.70 (-1.03%)
CDE : 21.44 (-0.69%)
ADI : 371.80 (-0.50%)
ABNB : 188.07 (-1.28%)
SCCO : 213.75 (-2.71%)
DOCS : 24.74 (unch)
SPY : 766.08 (+0.02%)
ADSK : 254.77 (+1.42%)
QQQ : 711.37 (+0.09%)
AU : 118.11 (-4.28%)
FTNT : 157.54 (+2.53%)
NOW : 125.80 (-0.94%)
Stocks Rally on Earnings and Fed-Friendly US Payroll Report

The S&P 500 Index ($SPX ) (SPY ) today is up +0.37%, the Dow Jones Industrial Average ($DOWI ) (DIA ) is up +0.14%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.89%. September E-mini S&P futures...

AMAT : 479.76 (-0.06%)
B : 47.00 (-3.83%)
HL : 20.70 (-1.03%)
CDE : 21.44 (-0.69%)
TTD : 13.03 (-1.66%)
ADI : 371.80 (-0.50%)
TXN : 261.77 (+0.66%)
ABNB : 188.07 (-1.28%)
$IUXX : 29,224.52 (+0.05%)
ASML : 1,745.64 (+0.08%)
ZNU26 : 108-220 (+0.03%)
NTRA : 338.45 (+0.52%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

Relative Strength is above 70%. The market is in overbought territory. Watch for a potential trend reversal.

See More Share

Business Summary

Natera, Inc. offers genetic testing and diagnostics with proprietary bioinformatics and molecular technology. Natera, Inc. is headquartered in San Carlos, California.

See More

Key Turning Points

3rd Resistance Point 349.51
2nd Resistance Point 345.24
1st Resistance Point 341.84
Last Price 338.45
1st Support Level 334.17
2nd Support Level 329.90
3rd Support Level 326.50

See More

52-Week High 340.96
Last Price 338.45
Fibonacci 61.8% 270.85
Fibonacci 50% 249.19
Fibonacci 38.2% 227.54
52-Week Low 157.43

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.